{{'Search' | translate}}
 

Pipetman L P200L, 20-200 μl

Company: Gilead
Catalog#: FA10005M
Bio-protocol()
Company-protocol()
Other protocol()

Colorimetric RT-LAMP and LAMP-sequencing for Detecting SARS-CoV-2 RNA in Clinical Samples
Author:
Date:
2021-03-20
[Abstract]  

During pandemics, such as the one caused by SARS-CoV-2 coronavirus, simple methods to rapidly test large numbers of people are needed. As a faster and less resource-demanding alternative to detect viral RNA by conventional qPCR, we used reverse transcription loop-mediated isothermal amplification (RT-LAMP). We previously established colorimetric RT-LAMP assays on both purified and unpurified SARS-CoV-2 clinical specimens and further developed a multiplexed sequencing protocol (LAMP-sequencing) to analyze the outcome of many RT-LAMP reactions at the same time (Dao Thi et al., 2020). Extending on this work, we hereby provide step-by-step protocols for both RT-LAMP assays and read-outs.

[摘要]  [摘要]在大流行期间(例如由SARS-CoV-2冠状病毒引起的大流行),需要一种简单的方法来快速测试大量人员。作为通过常规qPCR检测病毒RNA的一种更快且资源更少的替代方法,我们使用了逆转录环介导的等温扩增(RT-LAMP)。我们先前在纯化和未纯化的SARS-CoV-2临床标本上建立了比色RT-LAMP分析方法,并进一步开发了多重测序方案(LAMP测序)来同时分析许多RT-LAMP反应的结果(Dao Thi等)等人,2020年)。在此工作的基础上,我们在此提供针对RT-LAMP分析和读数的分步操作规程。

[背景]新的SARS-CoV-2冠状病毒构成了重大的公共卫生问题(Li等人,2020年综述)。在缺乏有效的抗病毒治疗和保护性疫苗的情况下,通过大量检测防止局部暴发至关重要。检测SARS-CoV-2感染的标准诊断流程基于以下条件:从临床标本中分离病毒RNA,将RNA转录为cDNA的逆转录(RT)反应以及通过半定量DNA聚合酶链反应进行检测(qPCR)(Corman等,2020)。然而,商业化的RNA分离和RT-qPCR试剂盒价格昂贵,耗时且大流行期间供应短缺,从而限制了高通量测试,需要其他解决方案(Klein等人,2020)。

在我们最近的研究中(Dao ...

Polyamine Transport Assay Using Reconstituted Yeast Membranes
Author:
Date:
2021-01-20
[Abstract]  

ATP13A2/PARK9 is a late endo-/lysosomal P5B transport ATPase that is associated with several neurodegenerative disorders. We recently characterized ATP13A2 as a lysosomal polyamine exporter, which sheds light on the molecular identity of the unknown mammalian polyamine transport system. Here, we describe step by step a protocol to measure radiolabeled polyamine transport in reconstituted vesicles from yeast cells overexpressing human ATP13A2. This protocol was developed as part of our recent publication (van Veen et al., 2020) and will be useful for characterizing the transport function of other putative polyamine transporters, such as isoforms of the P5B transport ATPases.

[摘要]  [摘要] ATP13A2 / PARK9是一种晚期内/溶酶体P5B转运ATPase,与多种神经退行性疾病有关。我们最近将ATP13A2表征为溶酶体多胺出口者,这为未知的哺乳动物多胺转运系统的分子身份提供了线索。在这里,我们逐步描述了从过量表达人ATP13A2的酵母细胞中测量重组囊泡中放射性标记的多胺转运的方案。该方案是我们最新出版物的一部分(van Veen等,2020),将有助于表征其他假定的多胺转运蛋白的转运功能,例如P5B转运ATPase的同工型。


[背景] ATP13A2 / PARK9编码一种普遍表达的晚期内-/溶酶体膜蛋白,与一系列神经退行性疾病有关,例如早发性帕金森氏病(Di Fonzo等,2007 ;Lin等,2008)和Kufor -Rakeb综合征(伴痴呆的早期帕金森病)(Ramirez等,2006 ;Park等,2011)。ATP13A2属于P型转运ATPase ,是一类活性转运蛋白,由于ATP水解而暂时形成磷酸中间产物(Kuhlbrandt ,2004年)。ATP13A2是P5亚家族的成员,该家族已在20多年前通过基因组测序鉴定出来(Axelsen和Palmgren ...

Comments